Skip to main content
Log in

Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium

  • Case Report
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A 53-year-old man with a 22-year history of ulcerative colitis(UC) (pancolitis), had an ulcerating rectal tumor. Resection of the rectum and sigmoid colon was performed. Pathology showed an expansive ulcerating adenocarcinoma tumor (type 2) invading the adventitia against a background of UC in a resolving phase. Dysplasia was also found in granular and flat mucosa adjacent to the invading carcinoma. Immunostaining for p53 showed diffuse positivity in both the carcinoma and dysplasia, and also in the mucosa with indefinite dysplasia or no dysplasia neighboring the dysplasia and carcinoma. Mapping of neoplasms and the area with p53 protein overexpression showed that the grade of dysplasia increased as the lesion approached the invasive carcinoma and that the mucosa with dysplasia was surrounded by mucosa without dysplasia or indefinite for dysplasia, but with p53 protein overexpression. In some areas without dysplasia showing p53 overexpression, there was significant morphometric enlargement of the area and diameter of the nucleus p53 Immunostaing is a good marker for assessing the genetic alterations that precede histological abnormalities and for diagnosing carcinoma in UC. Objective findings such as p53-protein overexpression and morphometric values should be used to evaluate cytological abnormalities in UC, as well as in common colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Goldgraber MB, Kirsner JB. Carcinoma of the colon in ulcerative colitis. Cancer 1964;17:657–665.

    PubMed  CAS  Google Scholar 

  2. Katza I, Brady RS, Morris E, et al. Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice. Gastroenterology 1983;85:22–29.

    Google Scholar 

  3. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: Standardised classification with provisional clinical applications. Hum Pathol 1983;14:931–968.

    PubMed  CAS  Google Scholar 

  4. Derroede GJ, Taylor WF, Sauer WG. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17–21.

    Google Scholar 

  5. Morson BC, Pang SC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1962;8:423–434.

    Google Scholar 

  6. Fuson JA, Farmer RG, Hawk WA, et al. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980;73:120–126.

    PubMed  CAS  Google Scholar 

  7. Hulten L, Kewenter J, Ahren C. Precancer and carcinoma in chronic ulcerative colitis: A histopathological and clinical investigation. Scand J Gastroenterol 1972;7:663–669.

    PubMed  CAS  Google Scholar 

  8. Cook MG, Goligher JC. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology 1975;68:1127–1136.

    PubMed  CAS  Google Scholar 

  9. Fenoglio CM, Pascal RR. Adenomatous epithelium, intraepithelial anaplasia, and invasive carcinoma in ulcerative colitis. Am J Dig Dis 1973;18:558–562.

    Article  Google Scholar 

  10. Gewertz BL, Dent TL, Appelman HD. Implications of precancerous rectal biopsy in patients with inflammatory bowel disease. Arch Surg 1976;111:326–329.

    PubMed  CAS  Google Scholar 

  11. Nugent FW, Haggitt RC, Colcher H, et al. Malignant potential of chronic ulcerative colitis: Preliminary report. Gastroenterology 1979;76:1–5.

    PubMed  CAS  Google Scholar 

  12. Yardley JH, Keren DF. “Precancer” lesions in ulcerative colitis: A retrospective study of rectal biopsy and colectomy specimens. Cancer 1974;34:835–844.

    PubMed  Google Scholar 

  13. Lennard-Jones JE, Morson BC, Ritchie JK, et al. Cancer in colitis: Assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977;73:1280–1289.

    PubMed  CAS  Google Scholar 

  14. Blackstone MO, Riddell RH, Rogers BHG, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy. Gastroenterology 1981;80:366–374.

    PubMed  CAS  Google Scholar 

  15. Dobbins WO III. Current status of the precancer lesion in ulcerative colitis. Gastroenterology 1977;73:1431–1433.

    PubMed  Google Scholar 

  16. Myrvold HE, Kock NG, Ahren C. Rectal biopsy and precancer in ulcerative colitis. Gut 1974;15:301–304.

    PubMed  CAS  Google Scholar 

  17. Watanabe H, Ajioka Y, Kobayashi M, et al. Early colorectal cancer and molecular biology (in Japanese). I to Cho (Stomach Intestine) 1994;29:171–180.

    Google Scholar 

  18. Nishikura K, Watanabe H, Kato N. Gatric microcarcinoma: Its histoligical varieties and differential diagnosis (in Japanese). I to cho (Stomach and Intestine) 1995;30:1295–1307.

    Google Scholar 

  19. Oohashi Y, Watanabe H, Ajioka Y, et al. p53 Immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol Int 1995;45:58–65.

    PubMed  CAS  Google Scholar 

  20. Matsuda K, Watanabe H, Ajioka Y, et al. Ulcerative colitis and colon cancer (in Japanese). Mol Med 1995;32:1158–1168.

    CAS  Google Scholar 

  21. Matsuda K, Watanabe H, Jass JR, et al. Incidence of p53-positive cells is different among histological phases of ulcerative colitis. Acta Med Biol 1995;43:197–203.

    Google Scholar 

  22. Kobayashi M, Watanabe H, Ajioka Y, et al. Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasia. Virchows Arch [A] 1995;427:27–32.

    CAS  Google Scholar 

  23. Kobayashi M, Watanabe H, Ajioka Y, et al. Effect of K-ras mutation on morphogenesis of colorectal adenomas and early cancers; relationship to distribution of proliferating cells. Hum Pathol (in press).

  24. Watanabe H, Ajioka Y, Yamaguchi M, et al. New histological criteria of colorectal adenoma and carcinoma (in Japanese). I to Cho (Stomach and Intestine). 1989;24:253–259.

    Google Scholar 

  25. Katagiri K, Watanabe H, Ajioka Y, et al. Importance of grading of cytologic atypia for well differentiated adenocarcinoma of the colorectum (in Japanese). I to Cho (Stomach and Intestine) 1994;29:841–849.

    Google Scholar 

  26. Ajioka Y, Watanabe H, Kobayashi M, et al. Ulcerative colitis-associated dysplasia and carcinoma: With special reference to their macroscopic and stereomicroscopic characteristics and histological diagnosis (in Japanese). I to Cho (Stomach and Intestine) 1995;30:629–642.

    Google Scholar 

  27. Japanese Research Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jpn J Surg 1983;13:557–573.

    Google Scholar 

  28. Watanabe H, Jass JR, Sobin LH. Histological typing of oesophageal and gastric tumours. 2nd ed. New York Berlin Heidelberg Tokyo: Springer, 1990:23.

    Google Scholar 

  29. Lewin KJ, Riddell RH, Weinstein WM. Gastrointestinal pathology and its clinical implications, vol 2. New York: Igaku-Shoin, 1992:929–949.

    Google Scholar 

  30. Pascal RR. Consistency in the terminology of colorectal dysplasia. Hum Pathol 1988;19:1249–1250.

    PubMed  CAS  Google Scholar 

  31. Pascal RR. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Hum Pathol 1994;25:1160–1171.

    PubMed  CAS  Google Scholar 

  32. Matsuda K, Watanabe H, Ajioka Y, et al. Diagnosis and treatment of colorectal microcarcinoma measuring 5 mm or less (in Japanese). I to Cho (Stomach and Intestine). 1995;30:1551–1564.

    Google Scholar 

  33. Campo E, Calle-Martin O, Miquel R et al. Loss of heterozygosity of p53 gene and p53 protein in human colorectal carcinomas. Cancer Res 1991;51:4436–4442.

    PubMed  CAS  Google Scholar 

  34. Rodrigues NR, Rowan A, Smith MEF, et al. p53 Mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555–7559.

    PubMed  CAS  Google Scholar 

  35. Purdie CA, O'Grady J, Piris J, et al. p53 expression in colorectal tumors. Am J Pathol 1991;138:807–813.

    PubMed  CAS  Google Scholar 

  36. Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335:675–679.

    Article  PubMed  CAS  Google Scholar 

  37. Baas IO, Mulder JWR, Offerhaus GJA, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5–12.

    Article  PubMed  CAS  Google Scholar 

  38. Taylor HW, Boyle M, Smith SC, et al. Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. Br J Surg 1993;80:442–444.

    PubMed  CAS  Google Scholar 

  39. Chaubert P, Benhatttar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994;144:767–775.

    PubMed  CAS  Google Scholar 

  40. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71–74.

    PubMed  CAS  Google Scholar 

  41. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934–944.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsuda, K., Watanabe, H., Ajioka, Y. et al. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium. J Gastroenterol 31, 860–867 (1996). https://doi.org/10.1007/BF02358616

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02358616

Key words

Navigation